ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 147 filers reported holding ASCENDIS PHARMA A/S in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,805,000 | +11.1% | 133,691 | 0.0% | 36.44% | -19.2% |
| Q2 2022 | $12,428,000 | -20.8% | 133,691 | 0.0% | 45.08% | -5.7% |
| Q1 2022 | $15,690,000 | -12.8% | 133,691 | 0.0% | 47.81% | +5.0% |
| Q4 2021 | $17,985,000 | +828.5% | 133,691 | +860.3% | 45.53% | +4092.7% |
| Q4 2019 | $1,937,000 | -90.1% | 13,922 | -93.2% | 1.09% | -85.5% |
| Q3 2019 | $19,658,000 | -16.4% | 204,088 | 0.0% | 7.51% | -2.6% |
| Q2 2019 | $23,501,000 | -2.2% | 204,088 | 0.0% | 7.71% | +23.3% |
| Q1 2019 | $24,021,000 | +87.9% | 204,088 | 0.0% | 6.25% | +48.9% |
| Q4 2018 | $12,786,000 | -5.8% | 204,088 | +6.5% | 4.20% | +40.2% |
| Q3 2018 | $13,576,000 | +6.5% | 191,588 | 0.0% | 3.00% | +9.1% |
| Q2 2018 | $12,744,000 | -35.5% | 191,588 | -36.6% | 2.74% | -36.3% |
| Q1 2018 | $19,751,000 | +46.6% | 302,009 | -10.2% | 4.30% | +13.9% |
| Q4 2017 | $13,471,000 | +30.3% | 336,264 | +17.9% | 3.78% | +32.8% |
| Q3 2017 | $10,336,000 | +1561.7% | 285,143 | +1173.0% | 2.85% | +1302.5% |
| Q2 2017 | $622,000 | -77.8% | 22,400 | -77.6% | 0.20% | -81.1% |
| Q1 2017 | $2,800,000 | -23.1% | 100,000 | -44.4% | 1.08% | -32.1% |
| Q4 2016 | $3,643,000 | – | 180,000 | – | 1.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |